These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23082441)

  • 1. Hypertension control in chronic kidney disease: don't miss the forest for the trees.
    Ong HT; Ong LM; Ho JJ
    Med J Malaysia; 2012 Aug; 67(4):359-62. PubMed ID: 23082441
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacologic Issues in treating hypertension in CKD.
    Sica DA
    Adv Chronic Kidney Dis; 2011 Jan; 18(1):42-7. PubMed ID: 21224029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial hypertension and proteinuria in pediatric chronic kidney disease.
    Simonetti GD; Bucher BS; Tschumi S; Lava SA; Bianchetti MG
    Minerva Pediatr; 2012 Apr; 64(2):171-82. PubMed ID: 22495191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protective effect of antihypertensive agents on renal insufficiency (REIN, RENAAL, IDNT, AASK, etc)].
    Tsuchida H; Kimura K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():617-22. PubMed ID: 15171445
    [No Abstract]   [Full Text] [Related]  

  • 5. Managing hypertension in patients with chronic kidney disease.
    Zuber K; Gilmartin C; Davis J
    JAAPA; 2014 Sep; 27(9):37-46. PubMed ID: 25148442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy for hypertension associated with kidney disease].
    Suzuki H
    Nihon Naika Gakkai Zasshi; 2003 Feb; 92(2):264-9. PubMed ID: 12652731
    [No Abstract]   [Full Text] [Related]  

  • 7. Complications of progression of CKD.
    Yang M; Fox CH; Vassalotti J; Choi M
    Adv Chronic Kidney Dis; 2011 Nov; 18(6):400-5. PubMed ID: 22098657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension Management in Transition: From CKD to ESRD.
    Valika A; Peixoto AJ
    Adv Chronic Kidney Dis; 2016 Jul; 23(4):255-61. PubMed ID: 27324679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of calcium channel blocker in hypertensive patients with chronic kidney disease].
    Morihira M; Kikuchi K; Nakagawa N; Fujino T; Hasebe N
    Nihon Jinzo Gakkai Shi; 2009; 51(4):451-5. PubMed ID: 19601552
    [No Abstract]   [Full Text] [Related]  

  • 10. Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk.
    Sciarretta S; Palano F; Tocci G; Baldini R; Volpe M
    Arch Intern Med; 2011 Mar; 171(5):384-94. PubMed ID: 21059964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical usefulness of RAAS inhibitors in hypertensive patients].
    Yamaguchi K; Sata M
    Nihon Rinsho; 2012 Sep; 70(9):1571-6. PubMed ID: 23012805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension in kidney transplant recipients.
    Ponticelli C; Cucchiari D; Graziani G
    Transpl Int; 2011 Jun; 24(6):523-33. PubMed ID: 21382101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy for hypertension associated with heart failure].
    Miyamoto H; Imaizumi T
    Nihon Naika Gakkai Zasshi; 2003 Feb; 92(2):258-63. PubMed ID: 12652730
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical trials on protective efficacy of antihypertensive agents for organ damage due to diabetes mellitus complicated with hypertension].
    Higashiura K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():623-7. PubMed ID: 15171446
    [No Abstract]   [Full Text] [Related]  

  • 15. [Management of hypertensive patients with cardiovascular damage].
    Tomiyama H; Takata Y; Yamashina A
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():612-6. PubMed ID: 15171444
    [No Abstract]   [Full Text] [Related]  

  • 16. [Resp-informations].
    Bouvier-Colle MH; Cot M; Le Goaster C
    Rev Epidemiol Sante Publique; 2000 Apr; 48(2):215-24. PubMed ID: 10804430
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertension.
    Ritter JM
    BMJ; 2011 Apr; 342():d1673. PubMed ID: 21474511
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of ARBs alone or with HCTZ in the treatment of hypertension and prevention of cardiovascular and renal complications.
    Greathouse MK; Weir MR
    Postgrad Med; 2012 Mar; 124(2):40-52. PubMed ID: 22437214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strengthening diuretics' role in hypertension.
    Manag Care; 2010 Sep; 19(9):46. PubMed ID: 20931893
    [No Abstract]   [Full Text] [Related]  

  • 20. Systemic hypertension and antihypertensive agents.
    Maschio G; Marcantoni C; Bernich P
    J Nephrol; 1999; 12 Suppl 2():S100-4. PubMed ID: 10688408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.